跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Nintedanib Esilate Soft Capsules
Approved
化学药品
Nintedanib Esilate Soft Capsules
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
May 6, 2022
Approval ID
8HfEYYm2jmH
Company
Boehringer Ingelheim International GmbH
Type
化学药品
Approval Details
Approval Id
8HfEYYm2jmH
Approval Number
国药准字HJ20170355
Generic Name
乙磺酸尼达尼布软胶囊
Generic Name En
Nintedanib Esilate Soft Capsules
Trade Name
维加特
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
按C₃₁H₃₃N₅O₄计算 150mg
Reg Date
2022-05-06
Expired Date
2027-05-05
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Catalent Germany Eberbach GmbH
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/catalent-germany-eberbach-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 6, 2022
Approval ID
8HfEYYm2jmH
Type
化学药品
Back to NMPA Approvals
维加特 - NMPA Drug Approval Details